PARIS–(BUSINESS WIRE)–TotalEnergies (Paris:TTE) (LSE:TTE) (NYSE:TTE) (35%, operator), together with its partners SOCAR (35%) and XRG (30%), have taken the Final Investment Decision (FID) for the Full Field Development of the Absheron gas and condensate field. Located in the Caspian Sea, 100 km south-east of Baku, the Absheron field holds approximately 140 billion cubic meters of recoverable gas reserves. A first development phase, with a production capacity of 1.5 billion cubic meters per ann
Month: September 2026
PARIS–(BUSINESS WIRE)–TotalEnergies (Paris:TTE) (LSE:TTE) (NYSE:TTE) (35%, operator), together with its partners SOCAR (35%) and XRG (30%), have taken the Final Investment Decision (FID) for the Full Field Development of the Absheron gas and condensate field. Located in the Caspian Sea, 100 km south-east of Baku, the Absheron field holds approximately 140 billion cubic meters of recoverable gas reserves. A first development phase, with a production capacity of 1.5 billion cubic meters per ann
PARIS–(BUSINESS WIRE)–TotalEnergies (Paris:TTE) (LSE:TTE) (NYSE:TTE) (35%, operator), together with its partners SOCAR (35%) and XRG (30%), have taken the Final Investment Decision (FID) for the Full Field Development of the Absheron gas and condensate field. Located in the Caspian Sea, 100 km south-east of Baku, the Absheron field holds approximately 140 billion cubic meters of recoverable gas reserves. A first development phase, with a production capacity of 1.5 billion cubic meters per ann
FOSTER CITY, California e WILMINGTON, Delaware–(BUSINESS WIRE)–Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) e Incyte (Nasdaq: INCY) oggi hanno annunciato che la Food and Drug Administration (FDA) statunitense ha approvato le compresse di Atebrioz™ (zilurgisertib) per ridurre il volume della nuova ossificazione eterotopica totale in pazienti adulti e pediatrici di almeno 12 anni di età affetti da fibrodisplasia ossificante progressiva. Il testo originale del presente annuncio, redatto nella ling
FOSTER CITY, Calif. & WILMINGTON, Del.–(BUSINESS WIRE)–Mirum Pharmaceuticals, Inc. (Nasdaq:MIRM) en Incyte (Nasdaq:INCY) hebben vandaag bekendgemaakt dat de Amerikaanse Food and Drug Administration (FDA) Atebrioz™ (zilurgisertib) tabletten heeft goedgekeurd voor het verminderen van het totale volume aan nieuwe heterotope ossificatie (HO) bij volwassen en pediatrische patiënten van 12 jaar en ouder met fibrodysplasia ossificans progressiva (FOP). Deze bekendmaking is officieel geldend in de or
FOSTER CITY, Californie et WILMINGTON, Delaware–(BUSINESS WIRE)–Mirum Pharmaceuticals, Inc. (Nasdaq : MIRM) et Incyte (Nasdaq : INCY) ont annoncé aujourd’hui que la Food and Drug Administration (FDA) américaine avait approuvé les comprimés d’Atebrioz™ (zilurgisertib) pour réduire le volume total des nouvelles ossifications hétérotopiques (HO) chez les patients adultes et pédiatriques âgés de 12 ans et plus atteints de fibrodysplasie ossifiante progressive (FOP). La posologie recommandée d’Ate
FOSTER CITY, Kalifornien und WILMINGTON, Delaware–(BUSINESS WIRE)–Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) und Incyte (Nasdaq: INCY) gaben heute bekannt, dass die US-amerikanische Food and Drug Adminstration (FDA) die Zulassung für Atebrioz™ (Zilurgisertib) Tabletten erteilt hat, die das Volumen der gesamten neuen heterotopischen Ossifikation (HO) bei erwachsenen und pädiatrischen Patienten mit Fibrodysplasia ossificans progressiva (FOP) im Alter von über 12 Jahren reduzieren sollen. Die em
FOSTER CITY (California) y WILMINGTON (Delaware)–(BUSINESS WIRE)–Mirum Pharmaceuticals, Inc. (Nasdaq:MIRM) e Incyte (Nasdaq:INCY) anunciaron hoy que la Administración de Alimentos y Medicamentos (FDA) de los Estados Unidos aprobó las tabletas de Atebrioz™ (zilurgisertib) para reducir el volumen de nueva osificación heterotópica (HO) total en pacientes adultos y pediátricos desde 12 años con fibrodisplasia osificante progresiva (FOP). El comunicado en el idioma original es la versión oficial y
Moody’s has affirmed the Government of Iceland’s domestic and foreign-currency long-term issuer and foreign-currency senior unsecured ratings at A1. The outlook remains stable.
The affirmation reflects Moody´s view that Iceland will continue to gradually diversify its export base, including through the development of new high-value sectors, although the economy will remain exposed to shocks in its three largest sectors. At the same time, proactive and well-coordinated policymaking will support macroeconomic stability and help reduce inflation. The affirmation also reflects the government’s strong commitment to fiscal consolidation, which Moody´s expects will support the continued rebuilding of fiscal buffers, albeit at a slower pace than in recent years.
The stable outlook reflects balanced risks at the A1 rating level. A stronger than expected contribution from new growth sectors could support sustainably higher growth and a faster improvement in Iceland’s fiscal prospects. Iceland has made significant progress in developing knowledge-intensive technology and health services and in shifting into higher value-added production within its traditional sectors, including aquaculture. Iceland’s proactive policymaking since the 2008 banking crisis has supported the accumulation of large macroeconomic buffers that enhance resilience to shocks. Strengthened financial sector regulation and macroprudential policy has improved banking system resilience. Households’ capacity to absorb shocks is supported by their strong balance sheets with historically low debt and very large pension assets given high mandatory funding of the system. The government’s strong commitment to fiscal consolidation will support the continued rebuilding of fiscal buffers which help to better insulate Iceland’s fiscal strength from shocks.
Iceland’s ratings could be upgraded if economic performance strengthens alongside policies which help to raise economic potential and support more stable growth over time, including through faster economic diversification which broadens the export base. Upward rating pressure could also emerge if Iceland’s fiscal metrics continue to improve, which leads to stronger fiscal buffers and a sustainable improvement in the affordability of government debt, reducing the susceptibility of fiscal strength to shocks.
Iceland’s ratings could be downgraded if a large shock caused lasting damage to key export sectors and materially weakened economic resilience. A deviation from the fiscal consolidation plans that led to a sustained deterioration in fiscal buffers, or substantial capital outflows that impaired external or financial stability, could lead to a downgrade. There could also be negative pressure on the rating if sustained high-wage growth in excess of productivity gradually eroded Iceland’s cost competitiveness and, over time, weighed on economic strength.
Read more on the Government of Iceland’s website
カリフォルニア州サンノゼ–(BUSINESS WIRE)–（ビジネスワイヤ） — インテリジェント・データ・インフラストラクチャー企業のネットアップ®（NASDAQ：NTAP）は、次世代メタデータ・アーキテクチャーと高性能並列ファイル・システムの先駆者であるPEAK:AIOを買収する意向を発表しました。今回の買収計画は、メタデータ・サービスを拡充するとともに、AIクラウドがGPUクラスターの拡大に合わせて共有ストレージを拡張できるよう設計された並列ネームスペース技術を強化することで、ネットアップのAIインフラ・ロードマップを加速すると見込まれています。 AIがあらゆるエンタープライズ・ワークロードに組み込まれるようになる中、組織は新たな課題に直面しています。従来のストレージ・アーキテクチャーは、AIファクトリー、AIクラウド、次世代のデータ集約型アプリケーションで求められる、これまでにない規模、同時処理能力、性能に関する要件を想定して設計されていませんでした。ネットアップは、メタデータとデータを分離し、メタデータ・サービスを独立して拡張できるアーキテクチャーを構築しており、数兆